Get started
TG THERAPEUTICS INCTG THERAPEUTICS INCTG THERAPEUTICS INC

TG THERAPEUTICS INC

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast

1TGTX chart


Full chart

1TGTX upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪4.94 B‬ EUR
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
142.960
Basic EPS (TTM)
0.250 EUR
Net income (FY)
‪22.59 M‬ EUR
Revenue (FY)
‪317.81 M‬ EUR
Shares float
‪142.95 M‬
Beta (1Y)
0.72

Employees


Employees (FY)
338
Change (1Y)
+74 +28.03%
Revenue / Employee (1Y)
‪940.27 K‬ EUR
Net income / Employee (1Y)
‪66.83 K‬ EUR

About TG Therapeutics, Inc.


Sector
Health Technology
Industry
Pharmaceuticals: Major
CEO
Michael Sean Weiss
Website
tgtherapeutics.com
Headquarters
Morrisville
Founded
1993
FIGI
BBG01TNWQXG1
TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

1TGTX news



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Check out other big names from the same industry as 1TGTX.

Frequently Asked Questions


The current price of 1TGTX is 31.385 EUR — it has increased by 1.60% in the past 24 hours. Watch TG THERAPEUTICS INC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on MIL exchange TG THERAPEUTICS INC stocks are traded under the ticker 1TGTX.
1TGTX stock has risen by 2.16% compared to the previous week, the month change is a −11.19% fall, over the last year TG THERAPEUTICS INC has showed a −11.19% decrease.
We've gathered analysts' opinions on TG THERAPEUTICS INC future price: according to them, 1TGTX price has a max estimate of 49.27 EUR and a min estimate of 9.85 EUR. Watch 1TGTX chart and read a more detailed TG THERAPEUTICS INC stock forecast: see what analysts think of TG THERAPEUTICS INC and suggest that you do with its stocks.
1TGTX reached its all-time high on May 2, 2025 with the price of 39.995 EUR, and its all-time low was 29.650 EUR and was reached on May 14, 2025. View more price dynamics on 1TGTX chart.
See other stocks reaching their highest and lowest prices.
1TGTX stock is 1.58% volatile and has beta coefficient of 0.72. Track TG THERAPEUTICS INC stock price on the chart and check out the list of the most volatile stocks — is TG THERAPEUTICS INC there?
Today TG THERAPEUTICS INC has the market capitalization of ‪4.94 B‬, it has decreased by −3.44% over the last week.
Yes, you can track TG THERAPEUTICS INC financials in yearly and quarterly reports right on TradingView.
TG THERAPEUTICS INC is going to release the next earnings report on Aug 5, 2025. Keep track of upcoming events with our Earnings Calendar.
1TGTX earnings for the last quarter are 0.03 EUR per share, whereas the estimation was 0.16 EUR resulting in a −82.53% surprise. The estimated earnings for the next quarter are 0.17 EUR per share. See more details about TG THERAPEUTICS INC earnings.
TG THERAPEUTICS INC revenue for the last quarter amounts to ‪111.71 M‬ EUR, despite the estimated figure of ‪108.96 M‬ EUR. In the next quarter, revenue is expected to reach ‪121.44 M‬ EUR.
1TGTX net income for the last quarter is ‪4.68 M‬ EUR, while the quarter before that showed ‪22.54 M‬ EUR of net income which accounts for −79.25% change. Track more TG THERAPEUTICS INC financial stats to get the full picture.
No, 1TGTX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of May 29, 2025, the company has 338 employees. See our rating of the largest employees — is TG THERAPEUTICS INC on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. TG THERAPEUTICS INC EBITDA is ‪55.53 M‬ EUR, and current EBITDA margin is 12.83%. See more stats in TG THERAPEUTICS INC financial statements.
Like other stocks, 1TGTX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade TG THERAPEUTICS INC stock right from TradingView charts — choose your broker and connect to your account.